| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $249.6M | +13.5% |
| Cost of Revenue | $71.1M | +3.0% |
| Gross Profit | $178.5M | +18.3% |
| R&D Expense | $14.1M | -9.7% |
| SG&A Expense | $42.0M | +15.9% |
| Operating Income | $67.9M | +30.0% |
| Interest Expense | $5.2M | +2428.8% |
| Pre-tax Income | $75.2M | +32.2% |
| Income Tax | $17.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.2M | +10.3% |
| Accounts Receivable | $33.6M | +11.8% |
| Current Assets | $468.2M | +16.4% |
| Total Assets | $615.7M | +11.6% |
| Current Liabilities | $36.3M | +18.7% |
| Total Liabilities | $222.2M | +3.6% |
| Stockholders' Equity | $393.5M | +16.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $81.3M | +84.1% |
| Investing Cash Flow | -$64.9M | +67.5% |
| Financing Cash Flow | -$14.5M | -109.2% |
| +35.9% |
| Net Income | $57.7M | +31.1% |
| EPS (Basic) | $2.55 | +30.1% |
| EPS (Diluted) | $2.52 | +30.6% |